Financial statements Pivexin Technology
Balance sheet data of PIVEXIN TECHNOLOGY
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 16 948 170,86 | 19 408 246,36 | 25 708 968,06 | 30 619 247,02 | 32 758 740,62 |
| A. Fixed assets | 8 695 837,30 | 8 752 637,67 | 12 778 644,02 | 12 793 141,76 | 14 440 952,15 |
| B. Current assets | 8 252 333,56 | 10 655 608,69 | 12 930 324,04 | 17 826 105,26 | 18 317 788,47 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 16 948 170,86 | 19 408 246,36 | 25 708 968,06 | 30 619 247,02 | 32 758 740,62 |
| A. Equity | 6 276 464,87 | 7 685 497,33 | 11 663 560,51 | 12 312 330,20 | 14 151 709,18 |
| B. Liabilities and provisions for liabilities | 10 671 705,99 | 11 722 749,03 | 14 045 407,55 | 18 306 916,82 | 18 607 031,44 |
| I. Long-term liabilities | 5 529 708,94 | 5 984 374,27 | 4 945 364,09 | 4 652 028,72 | 4 519 401,23 |
| II. Short-term liabilities | 5 141 997,05 | 5 738 374,76 | 9 008 354,82 | 13 586 121,62 | 14 041 785,89 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.